dartisla odt glycopyrrolate orally disintegrating tablets 1.7 mg

1 INDICATIONS & USAGE DARTISLA ODT is indicated in adults to reduce symptoms of a peptic ulcer as an adjunct to treatment of peptic ulcer. Limitations of Use DARTISLA ODT is not indicated as monotherapy for treatment of peptic ulcer because effectiveness in peptic ulcer healing has not been established. DARTISLA ODT is an anticholinergic indicated in adults to reduce symptoms of a peptic ulcer as an adjunct to treatment of peptic ulcer. Limitations of Use: Not indicated as monotherapy for treatment of peptic ulcer because effectiveness in peptic ulcer healing has not been established.

edenbridge pharmaceuticals llc.

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] fatigue` `[3] off label use` `[4] pain` `[5] nausea` `[6] headache` `[7] dyspnoea` `[8] diarrhoea` `[9] pyrexia` `[10] arthralgia`

12 months ago

ROUND WHITE double bridge

16 HOW SUPPLIED/STORAGE AND HANDLING DARTISLA ODT is supplied as: 0.85 mg glycopyrrolate as a white to off-white, round orally disintegrating tablet debossed with the symbol . Available as: NDC 82111-517-01: 30 orally disintegrating tablets per carton. Each carton has 3 blister cards containing 10 orally disintegrating tablets each. 1.7 mg glycopyrrolate as a white to off-white, round orally disintegrating tablets debossed with the symbol . Available as: NDC 82111-518-01: 30 orally disintegrating tablets per carton. Each carton has 3 blister cards containing 10 orally disintegrating tablets each. Store at 20°C to 25°C (68°F to 77°F); with excursions between 15°C to 30°C (59°F to 86°F) [USP controlled room temperature]. 0.85 1.7-debossing

More pills like ROUND double bridge

Related Pills

dartisla odt glycopyrrolate orally disintegrating tablets 0.85 mg

edenbridge pharmaceuticals llc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site